XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)

Grant

Date/time Interval

  • August 12, 2016 - September 23, 2019

    • Awarded By

    Total Award Amount

  • 86418.00

    • Direct Costs

  • 58788.00

    • Sponsor Award Id

  • 769K742

    • Contributor

  • Erica Stringer-Reasor M.D.   Investigator  
  • Helen Krontiras M.D.   Principal Investigator  
  • Jennifer De Los Santos   Investigator